Kingsview Wealth Management LLC boosted its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 4.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,444 shares of the company’s stock after purchasing an additional 644 shares during the period. Kingsview Wealth Management LLC’s holdings in Colgate-Palmolive were worth $1,603,000 as of its most recent SEC filing.
Several other institutional investors have also recently bought and sold shares of the business. Cerity Partners LLC increased its position in Colgate-Palmolive by 28.6% in the 3rd quarter. Cerity Partners LLC now owns 215,839 shares of the company’s stock valued at $22,406,000 after acquiring an additional 48,024 shares in the last quarter. Great Valley Advisor Group Inc. increased its holdings in shares of Colgate-Palmolive by 76.2% in the third quarter. Great Valley Advisor Group Inc. now owns 14,387 shares of the company’s stock valued at $1,494,000 after purchasing an additional 6,224 shares in the last quarter. Meridian Wealth Management LLC bought a new position in Colgate-Palmolive in the 3rd quarter worth approximately $1,133,000. AlphaCore Capital LLC lifted its holdings in Colgate-Palmolive by 21.9% during the 3rd quarter. AlphaCore Capital LLC now owns 4,454 shares of the company’s stock worth $462,000 after buying an additional 800 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in Colgate-Palmolive by 0.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 4,595,245 shares of the company’s stock valued at $477,032,000 after buying an additional 11,750 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.
Analysts Set New Price Targets
CL has been the subject of a number of research reports. Sanford C. Bernstein lifted their price objective on Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a research report on Tuesday, July 30th. StockNews.com upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday. TD Cowen cut their price objective on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Redburn Atlantic raised shares of Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. Finally, Morgan Stanley upped their target price on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the company an “overweight” rating in a research report on Monday, July 29th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average target price of $105.11.
Insider Transactions at Colgate-Palmolive
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.37% of the company’s stock.
Colgate-Palmolive Stock Performance
CL opened at $95.34 on Tuesday. The company has a market capitalization of $77.89 billion, a price-to-earnings ratio of 27.32, a P/E/G ratio of 3.39 and a beta of 0.42. The business’s 50-day moving average price is $97.90 and its two-hundred day moving average price is $98.58. Colgate-Palmolive has a 1 year low of $75.50 and a 1 year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.
Colgate-Palmolive Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.10%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- What is the Nasdaq? Complete Overview with History
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- The 3 Best Blue-Chip Stocks to Buy Now
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Discover the 3 Best Performing Stocks That Went Public in 2024
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.